Chris Miller
TitleCited byYear
Comprehensive genomic characterization defines human glioblastoma genes and core pathways
Cancer Genome Atlas Research Network
Nature 455 (7216), 1061, 2008
48612008
The cancer genome atlas pan-cancer analysis project
JN Weinstein, EA Collisson, GB Mills, KRM Shaw, BA Ozenberger, ...
Nature genetics 45 (10), 1113, 2013
26262013
Mutational landscape and significance across 12 major cancer types
C Kandoth, MD McLellan, F Vandin, K Ye, B Niu, C Lu, M Xie, Q Zhang, ...
Nature 502 (7471), 333, 2013
26032013
VarScan 2: Somatic mutation and copy number alteration discovery in cancer by exome sequencing
DC Koboldt, Q Zhang, DE Larson, D Shen, MD McLellan, L Lin, CA Miller, ...
Genome Research 22 (3), 568-576, 2012
24752012
Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia
TCGAR Network
New England Journal of Medicine 368 (22), 2059-2074, 2013
2241*2013
Comprehensive molecular profiling of lung adenocarcinoma
Cancer Genome Atlas Research Network
Nature 511 (7511), 543, 2014
19572014
Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing
L Ding, TJ Ley, DE Larson, CA Miller, DC Koboldt, JS Welch, JK Ritchey, ...
Nature, 2012
16802012
The Origin and Evolution of Mutations in Acute Myeloid Leukemia
JS Welch, TJ Ley, DC Link, CA Miller, DE Larson, DC Koboldt, ...
Cell 150 (2), 264-278, 2012
11252012
Age-related mutations associated with clonal hematopoietic expansion and malignancies
M Xie, C Lu, J Wang, MD McLellan, KJ Johnson, MC Wendl, ...
Nature medicine 20 (12), 1472, 2014
9102014
Whole-genome analysis informs breast cancer response to aromatase inhibition
MJ Ellis, L Ding, D Shen, J Luo, VJ Suman, JW Wallis, BA Van Tine, ...
Nature 486 (7403), 353, 2012
8762012
Endocrine-therapy-resistant ESR1 variants revealed by genomic characterization of breast-cancer-derived xenografts
S Li, D Shen, J Shao, R Crowder, W Liu, A Prat, X He, S Liu, J Hoog, C Lu, ...
Cell reports 4 (6), 1116-1130, 2013
4092013
Role of TP53 mutations in the origin and evolution of therapy-related acute myeloid leukaemia
TN Wong, G Ramsingh, AL Young, CA Miller, W Touma, JS Welch, ...
Nature 518 (7540), 552, 2015
3872015
TP53 and Decitabine in Acute Myeloid Leukemia and Myelodysplastic Syndromes
JS Welch, AA Petti, CA Miller, CC Fronick, M O’Laughlin, RS Fulton, ...
New England Journal of Medicine 375 (21), 2023-2036, 2016
3302016
DGIdb: mining the druggable genome
M Griffith, OL Griffith, AC Coffman, JV Weible, JF McMichael, NC Spies, ...
Nature methods 10 (12), 1209, 2013
3032013
Functional heterogeneity of genetically defined subclones in acute myeloid leukemia
JM Klco, DH Spencer, CA Miller, M Griffith, TL Lamprecht, M O’Laughlin, ...
Cancer cell 25 (3), 379-392, 2014
2672014
SciClone: inferring clonal architecture and tracking the spatial and temporal patterns of tumor evolution
CA Miller, BS White, ND Dees, M Griffith, JS Welch, OL Griffith, R Vij, ...
PLoS computational biology 10 (8), e1003665, 2014
2632014
Clonal diversity of recurrently mutated genes in myelodysplastic syndromes
MJ Walter, D Shen, J Shao, L Ding, BS White, C Kandoth, CA Miller, B Niu, ...
Leukemia 27 (6), 1275-1282, 2013
2362013
The R882H DNMT3A mutation associated with AML dominantly inhibits wild-type DNMT3A by blocking its ability to form active tetramers
DA Russler-Germain, DH Spencer, MA Young, TL Lamprecht, CA Miller, ...
Cancer cell 25 (4), 442-454, 2014
2352014
Association between mutation clearance after induction therapy and outcomes in acute myeloid leukemia
JM Klco, CA Miller, M Griffith, A Petti, DH Spencer, S Ketkar-Kulkarni, ...
Jama 314 (8), 811-822, 2015
2102015
Background mutations in parental cells account for most of the genetic heterogeneity of induced pluripotent stem cells
MA Young, DE Larson, CW Sun, DR George, L Ding, CA Miller, L Lin, ...
Cell stem cell 10 (5), 570-582, 2012
1992012
The system can't perform the operation now. Try again later.
Articles 1–20